News
-
-
-
-
-
PRESS RELEASE
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases -
-
-
PRESS RELEASE
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
Immunic, Inc. strengthens its board with the appointment of experienced pharmaceutical executive Simona Skerjanec, known for leading successful commercial launches in MS therapy -
-